Confronto

Epitalon vs. Selank

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

307297-39-8

129954-34-3

Peso molecolare

390.35 g/mol

751.85 g/mol

Emivita

0.3 h

Sequenza

Ala-Glu-Asp-Gly

Thr-Lys-Pro-Arg-Pro-Gly-Pro

Meccanismo d'azione

Epitalon

Postulated mechanisms include modulation of gene expression in pinealocytes, telomerase activation (observed in cell culture studies) and influence on melatonin synthesis. A defined primary receptor is not established; the mechanistic basis rests on in-vitro and animal data from the Khavinson group.

Selank

Selank is a glyproline-tuftsin analog. Proposed mechanisms include modulation of the GABAergic system, effects on serotonin bioavailability, and influence on enkephalinases. Animal studies show anxiolytic and neuroprotective markers; a clear receptor target is not established.

Base di evidenze

Evidenza più alta

Studio sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Epitalon	Selank
Germania	Non approvato	Non approvato
RU	Solo ricerca	Su prescrizione
Stati Uniti	Non approvato	Non approvato

Voci complete

Frequently asked questions

What is the difference between Epitalon and Selank?: Epitalon is classified as "Ricerca (altro)", while Selank is classified as "Ricerca (altro)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Selank: Synthetic heptapeptide derived from natural tuftsin. Approved as an anxiolytic (Selank) in Russia and some CIS states. Western phase-3 trials are absent; efficacy assessment relies on Russian research literature. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Epitalon or Selank?: The highest available evidence level is "Studio sull'uomo" for Epitalon and "Studio sull'uomo" for Selank. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Epitalon and Selank in Germany and the United States?: Germania: Epitalon — Non approvato, Selank — Non approvato. Stati Uniti: Epitalon — Non approvato, Selank — Non approvato. These are factual summaries with source and review date on the individual pages.

Country

Epitalon

Selank

Germania

Non approvato

Solo ricerca

Su prescrizione

Stati Uniti

Non approvato

Frequently asked questions

What is the difference between Epitalon and Selank?

Epitalon is classified as "Ricerca (altro)", while Selank is classified as "Ricerca (altro)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Selank: Synthetic heptapeptide derived from natural tuftsin. Approved as an anxiolytic (Selank) in Russia and some CIS states. Western phase-3 trials are absent; efficacy assessment relies on Russian research literature. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Epitalon or Selank?

The highest available evidence level is "Studio sull'uomo" for Epitalon and "Studio sull'uomo" for Selank. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Epitalon and Selank in Germany and the United States?

Germania: Epitalon — Non approvato, Selank — Non approvato. Stati Uniti: Epitalon — Non approvato, Selank — Non approvato. These are factual summaries with source and review date on the individual pages.